
Featured
WHO Endorses CRISPR-Enhanced Bacteriophage Therapy as First-Line Treatment for Carbapenem-Resistant Infections
The WHO has endorsed CRISPR-enhanced bacteriophage therapy as a first-line treatment for carbapenem-resistant infections based on the PHAGE-CR trial. ...
Read Full Story →

